Proceedings of the 2019 Viral Clearance Symposium, Session 8. Conference Summary: Key Discussion and Outcomes, Pending Questions, and Proposed Experiments and Actions

References

1. 1.↵
   U.S. Food and Drug Administration. International Conference on Harmonisation; Guidance on Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin; Availability. Fed. Regist. 1998, 63 (185), 51074–51084.

   OpenUrlPubMed
2. 2.↵
   European Medicines Agency, Meeting Report: Joint BWP/QWP Workshop with Stakeholders in Relation to Prior Knowledge and Its Use in Regulatory Applications. EMA: London, 2018.